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Human genetic variation is expected to play a central role in personalized medicine. Yet only a fraction of the natural
genetic variation that is harbored by humans has been discovered to date. Here we report almost 2 million small insertions
and deletions (INDELs) that range from 1 bp to 10,000 bp in length in the genomes of 79 diverse humans. These variants
include 819,363 small INDELs that map to human genes. Small INDELs frequently were found in the coding exons of these
genes, and several lines of evidence indicate that such variation is a major determinant of human biological diversity.
Microarray-based genotyping experiments revealed several interesting observations regarding the population genetics of
small INDEL variation. For example, we found that many of our INDELs had high levels of linkage disequilibrium (LD) with
both HapMap SNPs and with high-scoring SNPs from genome-wide association studies. Overall, our study indicates that
small INDEL variation is likely to be a key factor underlying inherited traits and diseases in humans.
[Supplemental material is available for this article. The microarray data from this study have been submitted to the NCBI
Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo) under accession no. GSE27889. The INDEL variants
reported in this study have been deposited in the NCBI dbSNP database (http://www.ncbi.nlm.nih.gov/projects/SNP/)
(a complete listing of the accession numbers can be found in Supplemental Table 17).]
The age of personalized genomics is well under way. Human ge-
nomes are being sequenced at unprecedented rates (Levy et al.
2007; Bentley et al. 2008; Ley et al. 2008;Wang et al. 2008;Wheeler
et al. 2008; Ahn et al. 2009; Kim et al. 2009; McKernan et al. 2009;
The 1000Genomes Project Consortium2010; Schuster et al. 2010),
and projects are under way to sequence the genomes of at least
1000 additional humans (Hayden 2008; The 1000 Genomes
Project Consortium 2010). The long-range goal of these studies is
to ‘‘crack the code’’ of natural genetic variation, i.e., to understand
how changes in our genetic blueprints influence human traits. The
prime motivation for these studies is to improve human health by
understanding how genetic variation affects health, diseases, and
medical treatments. Personal genome sequences will be used to
predict the future health of individuals and to develop customized
medical treatments that are optimized based on the genetic vari-
ation that is detected.
A critical first step in this process is to gain a comprehensive
knowledge of the genetic variation that is harbored by human
populations and to develop databases of informative variants that
can be used to predict human health. Several types of natural ge-
netic variation have been identified in humans, including single
nucleotide polymorphisms (SNPs) (The International SNP Map
Working Group 2001; The International HapMap Consortium
2003, 2005; The 1000 Genomes Project Consortium 2010), small
insertions and deletions (INDELs) ranging from 1 bp to 10 kb in
length (Weber et al. 2002; Bhangale et al. 2005; Mills et al. 2006;
Korbel et al. 2007; Kidd et al. 2008; The 1000 Genomes Project
Consortium 2010), and larger structural variants ranging from 10
kb to several megabases in length (Iafrate et al. 2004; Sebat et al.
2004; Tuzun et al. 2005; Conrad et al. 2006, 2010a,b; Hinds et al.
2006; McCarroll et al. 2006; Kidd et al. 2008; The 1000 Genomes
Project Consortium 2010; Mills et al. 2011). Minisatellites, micro-
satellites, and transposon insertions also have been identified
within these variant classes (Weber et al. 2002; Mills et al. 2006,
2007). Although SNPs and larger structural variants have received
considerable attention, small INDELs remain largely under-discovered,
andmethods for studying these INDELs have laggedbehindmethods
for analyzing other forms of variation. As a consequence, we know
relatively little about the impact of small INDEL variation on human
biology and diseases.
In this study, we identified almost 2 million small INDELs in
the genomes of 79 diverse humans. More than 800,000 of these
small INDELs mapped to human genes, including the coding
exons and promoters of these genes. Several lines of evidence in-
dicate that coding INDELs in particular are likely to affect gene
function in humans. We also developed new microarray-based
INDEL genotyping technologies to study the population genetics
of small INDELs in diverse humans.Overall, our study indicates that
small INDEL variation is extensive in human genomes and is likely
to have a major impact on human biology and diseases.
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Results
Small INDEL discovery using DNA sequencing data
from 79 humans
To gain a better understanding of small INDEL variation in human
populations, we examined 98million Applied Biosystems (Sanger)
DNA re-sequencing traces that had been deposited into the trace
archive at the National Center for Biotechnology Information
(NCBI) (Supplemental Table 1). Many of these traces were gener-
ated previously by genome centers for SNP discovery projects or for
BAC sequencing projects that were not used in published genome
assemblies. Traces that were generated from targeted, PCR-based
re-sequencing projects were excluded from our analysis. The final
trace set includes DNA sequence information from 79 diverse
humans, making it an ideal resource for variation discovery (Sup-
plemental Table 2). We confirmed that these traces provide excel-
lent coverage of the human genome (Supplemental Fig. 1).
By comparing these 98 million traces to build hg18 of the
reference human genome sequence (The International Human
Genome Sequencing Consortium 2001), we identified 1.96 mil-
lion nonredundant small INDELs from an initial discovery set of
3.4 million INDELs (Table 1; Supplemental Tables Chr1–ChrY; see
Methods). We previously established that our INDEL discovery
pipeline has a validation rate of 97.2% (Mills et al. 2006; please see
Methods). We also determined that 1.36 million of the 1.96 mil-
lion INDELs in this study (69.3%) were discovered in more than
one independent trace or could be confirmed in the chimpanzee
(The Chimpanzee Sequencing and Analysis Consortium 2005) or
Celera (Venter et al. 2001) genomes (Table 1). Thus, additional
validation was achieved through these comparisons.
Our INDELs were found on all 24 human chromosomes at an
average spacing of one INDEL per 1589 bp of DNA. They ranged
from 1 bp to 10,000 bp in length and followed a size distribution in
which the majority of INDELs were <100 bp in length (Supple-
mental Fig. 2; Wheeler et al. 2008). Like known SNPs, which affect
;15 Mb of DNA (dbSNP build 129), our INDEL variants affected
11.9 Mb of the human genome. Thus, the amount of genetic
variation that is caused by small INDELs, in terms of base pairs, is
considerable and approaches that caused by known SNPs.
Comparisons with personal human genomes and populations
We next wished to compare our 1.96 million variants to the small
INDELs that have been discovered in personal human genomes
and populations. We first compared our variants to the INDELs
that that have been deposited to dbSNP and found that 37%
(726,871/1.96 million) of our INDELs had been deposited pre-
viously. Thus, 63% of our INDELs are novel compared to the
INDELs in dbSNP (build 129). We also examined five of the per-
sonal human genomes that have been sequenced, including four
‘‘healthy’’ genomes (Levy et al. 2007; Bentley et al. 2008; Wang
et al. 2008; Wheeler et al. 2008) and the genome of a patient with
acutemyelogenous leukemia (Ley et al. 2008). Twenty-two percent
(432,958) of our 1.96 million INDELs were present in one or more
of these genomes (Fig. 1; Supplemental Table 3). Finally, we com-
pared our INDELs to the 1.48 million INDELs that recently were
reported by the 1000Genomes Project (Fig. 1C; The 1000Genomes
ProjectConsortium2010).We determined that 463,377 of our 1.96
million INDELs (23.6%)were present in the 1000Genomes Project
data set (Fig. 1C). The relatively small overlap between our INDELs
and the INDELs from these other studies (Fig. 1; Supplemental
Table 3; dbSNP) suggests that INDEL discovery is likely to be in-
complete in human populations.
Structural variants (SVs) and transposon insertions
Our INDEL discovery range (of 1 bp to 10,000 bp) overlaps the
discovery ranges that have been defined for structural variants
(SVs), copy number variants (CNVs), and transposon insertions.
For example, the 1000 Genomes Project recently defined SVs as
variants that are >50 bp in length (The 1000 Genomes Project
Consortium2010;Mills et al. 2011), and other groups have defined
SVs as variants that are >1 kb (Iafrate et al. 2004). We identified
7245 variants that are >50 bp and 957 variants that are >1000 bp
among our collection of 1.96 million INDELs (Table 1; Supple-
mental Table 4). Thus, a small fraction of our 1.96 million INDELs
(0.4%) overlaps these larger variant classes. We compared these
7245 variants to: (1) SVs in the Database of Genomic Variants
(Iafrate et al. 2004), (2) SVs that were reported recently by Conrad
et al. (2010a,b), and (3) SVs that were reported recently by The
1000 Genomes Project Consortium (2010) (Mills et al. 2011). We
found that 3582 of our 7245 variants (49.4%)were novel compared
to these other variants (Supplemental Table 4). Many of the
remaining 3663 variants provide breakpoint resolution for known
SVs at the single-nucleotide level for the first time. We also sus-
pected that some of our INDELs might have been caused by trans-
poson insertions (Supplemental Fig. 2). Indeed, 1150 transposon
Table 1. Summary of small INDELs identified from 98 million
re-sequencing traces
Traces screened 98,350,511
Bases analyzed (trimmed) 42,000,606,219
Reference human genome (hg18) 3,107,677,273
Cumulative coverage 13.53
Variants identified 3,400,787
Unique (nonredundant) variants 1,955,656
Insertions 978,721
Deletions 976,935
Total bases affected 11,909,159
Total double hit 1,355,228
Match chimp allele 878,574
Match celera allele 648,941
Match variant allele 688,990
Total double center 477,295
Transposon insertions (with TSDs) 1150
Alu 1004
L1-Ta/pre-Ta 70
SVA 58
INDELs overlapping SV size range
>50 bp 7245
>1000 bp 957
98 million human traces were obtained from the NCBI Trace Archive and
were compared to the reference human genome to identify potential
variants. All of the data were assembled into a MySQL database and de-
posited into dbSNP (Supplemental Tables Chr1–ChrY). INDEL-positive
traces were compared to (a) other INDEL-positive traces, (b) the chimp
genome (The Chimpanzee Sequencing and Analysis Consortium 2005),
and (c) the Celera genome (Venter et al. 2001) to determine whether the
allele was identified in other genomes and could be classified as a ‘‘double
hit’’ allele. INDEL-positive traces from independent projects and centers
were tracked to provide independent confirmation (Supplemental Tables
Chr1–ChrY). INDELs were mapped to the promoters, 59 and 39 UTRs,
splice sites, and introns of genes. This and other annotations were tracked
in a MySQL database (and are listed in Supplemental Tables Chr1–ChrY).
INDELs that were caused by Alu, L1, and SVA retrotransposon insertions
are listed in Supplemental Table 16.
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insertions were identified in our INDEL collection, including Alu,
L1, and SVA insertions (Table 1; Supplemental Table 16). A total of
170/1150 (14.8%) of these insertions previously were identified by
our laboratory using transposon-seq methodologies (Iskow et al.
2010).
Small INDELs in human genes
Although INDELs could, in principle, af-
fect a number of functional elements in
the human genome, of particular interest
are variants that alter human genes. A
large number (819,363 or 42%) of the
1.96 million INDELs in this study map-
ped to known human genes, and 2123
INDELs (0.1%) affected the coding exons
of these genes (Fig. 2; Supplemental Fig.
3; Supplemental Table 5). These ‘‘coding
INDELs’’ were identified by comparing
the coordinates of our INDELs to those of
annotated RefSeq and Ensembl genes
(build hg18). An initial set of 1715 coding
INDELs was identified that affected 990
of the 20,705 RefSeq genes that were ex-
amined (equivalent to 4.8% of the RefSeq
genes). An additional 408 coding INDELs
were identified in 215 Ensembl genes that
were not annotated in the RefSeq collec-
tion. Thus, a combined total of 1300
exons and 1205 genes were affected by
coding INDELs in our collection (equiva-
lent to ;5.8% of the genes in the human
genome). These data indicate that appar-
ently healthy humans harbor a sub-
stantial genetic load of coding INDELs.
A total of 184 of our 2123 (8.7%)
coding INDELs overlapped one or more
exon boundaries, and these variants
generally would be expected to abolish
gene function (Supplemental Fig. 3; Sup-
plemental Table 5). The remaining cod-
ing INDELs (1939/2123 or 91.3%) fell
entirely within coding exons. More than half of these INDELs
(1037/1939 or 53.5%) would be expected to cause frameshifts that
would introduce premature termination codons (PTCs). Some of
these PTCs are predicted to occur at positions that would target the
encoded mRNA for nonsense-mediated decay (NMD), and such
variants generally would abolish gene function. However, PTCs
that occur in the final 39 exon (or in the 39 50 nt of the penultimate
exon)may producemRNAs that escape NMD; thesemRNAs could,
in principle, encode novel proteins that have gain-of-function or
dominant-negative effects. The remaining coding INDELs (902/
1939 or 46.5% of those within exons) were multiples of 3 nt, and
thus, maintained the open reading frames (ORFs) of the original
proteins (Supplemental Table 5).
Many (357/1205 or 29.6%) genes were affected indepen-
dently by two or more coding INDELs (Supplemental Fig. 4; Sup-
plemental Table 5). For example, nine in-frame exon variants of
theDSPP gene (involved in the development of the dentin portion
of teeth) (Mastrangelo et al. 2007) were identified (Supplemental
Table 5). It is tempting to speculate that such polymorphisms
might play a role in dental health. Moreover, 14 coding exon
variants of the EP400 tumor suppressor gene (Fuchs et al. 2001)
were identified (Supplemental Table 5). A total of 52 genes that
previously have been implicated in human cancers harbored
coding INDELs (Supplemental Table 5). At least four gene families
that previously were known to be highly polymorphic in human
Figure 1. Comparisons of our data with small INDELs identified from
other projects. (A,B) Diagrams comparing the 1.96 million INDELs dis-
covered in this study with the small INDELs that were identified in four
personal genomes. (A) Comparison of our 1.96 million INDELs (light blue,
top) with Venter (Levy et al. 2007) and Watson (Wheeler et al. 2008)
INDELs. (B) Comparison of our 1.96 million INDELs (light blue, top) with
Han Chinese (Wang et al. 2008) and Yoruban (Bentley et al. 2008) INDELs,
(C ) Comparison of our 1.96 million INDELs (light blue, top) with the 1.48
million INDELs identified by the 1000 Genomes Project (1000GP) (The
1000 Genomes Project Consortium 2010).
Figure 2. Distribution of coding exon variants in the human genome. (A) The figure depicts a typical
RefSeq gene and its features. 819,363 small INDELs from our study were mapped to RefSeq genes. The
INDEL-to-SNP ratios for each genomic compartment are indicated. (B) The 1205 genes that were af-
fected by 2123 coding exon variants (Supplemental Table 5) are indicated on the map of human
chromosomes (colored marks to the left of the chromosomes indicate an affected gene). Each mark is
indexed by color to indicate gene function (and is cross-referenced to the pie chart below). A redmark to
the right of each chromosome indicates that the affected gene previously was linked to a known disease.
The pie chart shows the functional breakdown of the coding variants.
Mills et al.
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populations (Hughes and Yeager 1998; Shimomura et al. 2002;
Suzuki et al. 2002; Gilad and Lancet 2003) also carried a large
number of coding INDELs. In particular, 46 exon variants were
identified in 23 different keratin genes; 14 exon variants were
identified in seven collagen genes; 40 exon variantswere identified
in 32 olfactory receptor genes; and 11 exon variantswere identified
in two HLA genes (Supplemental Fig. 4; Supplemental Table 5).
Thus, coding INDELs contribute to the high levels of genetic var-
iation that are characteristic of these gene families. In each case,
these high levels of genetic variation are known to be maintained
for a biological purpose (Hughes and Yeager 1998; Shimomura
et al. 2002; Suzuki et al. 2002; Gilad and Lancet 2003). These ex-
amples, along with the many additional examples in Supplemen-
tal Table 5, illustrate the point that coding INDELsmay potentially
cause a great deal of human biological diversity.
Coding INDELs that are likely to cause human phenotypes
We next set out to identify INDELs that are likely to cause phe-
notypic consequences in humans. Although some of our coding
INDELs could, in principle, cause gain-of-function phenotypes,
our analysis was focused solely on human INDELs that would
disrupt gene function. To identify INDELs that are likely to be
disruptive in humans, we identified INDELs that (1) reside within
coding exons and cause frameshifts or overlap exon boundaries,
(2) affect more than just the last exon, and (3) affect all Ensembl
transcripts for the overlapped gene. Filtering on these three criteria
resulted in548 INDELs that affect 394humangenes (Supplemental Table
5). To gain insight into the likely phenotypic consequences of these dis-
ruptions, we identified 101 genes from this set that are associated with
targeted disruption phenotypes in the mouse (Supplemental Table 6;
Eppig et al. 2005, 2007). Of these 101 experimentally disrupted genes, 84
(83%)yieldanabnormalphenotypeuponhomozygousdisruption in the
mouse (Supplemental Table 6).
We also identified five additional genes for which heterozy-
gous disruptions are known to cause human diseases. As might be
expected, the human disorders that are associated with these gene
disruptions are nonlethal, often are late-onset, and are associated
with relatively mild or variable phenotypes that might easily go
undetected. The five genes, and their associated diseases, are CEL
(maturity-onset diabetes of the young; OMIM: 609812) (Raeder
et al. 2006), IRAK3 (early onset asthma; OMIM: 611064) (Balaci
et al. 2007), KRT14 (ectodermal dysplasia syndromes; OMIM:
161000 and 125595) (Lugassy et al. 2006), MYO6 (progressive
hearing loss; OMIM: 606346) (Sanggaard et al. 2008; Hilgert et al.
2008), and RP1 (retinitis pigmentosa; OMIM: 180100) (Supple-
mental Table 6; Guillonneau et al. 1999; Pierce et al. 1999; Sullivan
et al. 1999). Three additional human genes with disruptive
INDELs have mouse orthologs that are being used as human
disease models in the hemizygous state. These are CACNA1F
(congenital stationary night blindness; OMIM: 300071) (Mansergh
et al. 2005), NBN (Nijmegen Breakage Syndrome; OMIM: 251260)
(Dumon-Jones et al. 2003; Resnick et al. 2003; Tanzanella et al.
2003), and TCOF1 (Treacher Collins syndrome; OMIM: 154500)
(Supplemental Table 6; Dixon et al. 2000;Marzalek et al. 2003; Shoo
et al. 2004). These analyses indicate that at least some of our INDELs
are likely to have phenotypic consequences in humans, even when
present in just one copy.
Evidence for strong purifying selection on coding INDELs
To investigate whether purifying selection might act on coding
INDELs (particularly those that are detrimental), we next exam-
ined the relative distributions of INDELs compared to SNPs in the
human genome. Our computational pipeline simultaneously de-
tects both INDELs and SNPs from ABI trace data, and has high
levels of accuracy with both classes of variation (Tsui et al. 2003;
Mills et al. 2006; please see Methods). We determined that the
genome-wide ratio of INDELs to SNPs was 0.19 (i.e., 1 INDEL for
every 5.3 SNPs) (Supplemental Table 7). Both genes and intergenic
regions had ratios that were similar to this genome-wide average
(0.20 vs. 0.18, respectively) (Fig. 2A). Although most gene features
(promoters, introns, terminators) also had similar ratios (Fig. 2A),
the ratio for coding exons was well below this genome-wide aver-
age (0.046) (Fig. 2A). We confirmed that this difference was caused
by a reduction of INDELs. This difference is most likely explained
by the fact that INDELs create major changes in coding exons
(including frameshifts and amino acid changes), whereas SNPs
often produce synonymous changes that have little or no impact
on gene function. Thus, strong purifying selection appears to
eliminate INDELs thatmap to coding exonsmuchmore frequently
than SNPs. Despite these reductions, coding INDELs were still
fairly abundant in the genomes examined, indicating that coding
INDELs are nevertheless likely to have a substantial impact on
humans (see also below).
Microarrays for genotyping small INDELs in humans
Although microarrays have been used widely to genotype SNPs
(The International HapMap Consortium 2003, 2005) and rela-
tively large structural variants (Sebat et al. 2004; Conrad et al. 2006,
2010a; Hinds et al. 2006; McCarroll et al. 2006; Mills et al. 2011),
microarray-based assays for interrogating small human INDELs
have received little attention. This is particularly true for INDELs in
the size range of 1 bp to 100 bp, which account for ;99% of the
INDELs in our study. As a consequence, we lack robust tools to
study our INDELs and the small INDELs that are being discovered
in personal human genomes. Thus, we set out to develop new
genotyping methods to interrogate small INDELs on microarrays.
In particular, we developed assays to genotype INDELs that are 1 bp
to 100 bp in length.We sampled several commercial platforms and
found that the most successful approach was to adapt methods
that originally were developed for the Affymetrix 5.0 and 6.0 SNP
arrays (The International HapMap Consortium 2005). Like these
arrays, we used reduced representation and statistical probe clus-
tering models to develop assays for INDEL genotyping (Fig. 3).
However, in contrast to Affymetrix SNP arrays, our probe sets were
designed to specifically interrogate novel junctions that define
small INDELs using a series of overlapping 25-mer probes (Sup-
plemental Fig. 5). The probe design protocols, library files, and
Affymetrix Power Tools (APT) software packages were modified
accordingly to accommodate the unique format of our custom
INDEL data. Overall, successful probe sets with good BRLLM-P
clustering characteristics were developed for 10,003 INDELs using
a confidence cutoff of 0.05 (Fig. 3D; Supplemental Table 8;
Methods). Trace frequency data indicate that these 10,003 INDELs
were representative of the larger INDEL collection (Supplemental
Fig. 6). As a measure of accuracy, we also performed validation
studies on a representative set of INDELs using PCR methodolo-
gies. The vast majority (268/271 or 99%) of the genotyping calls
were identical for the two sets of measurements (Fig. 3D; Supple-
mental Table 9). Likewise, arrays that were hybridized with the
same genomic DNA probes on separate days had >99% identical
calls, indicating that our methods are highly reproducible (Sup-
plemental Table 8).
Small INDELs in human genomes
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Population genetics of small INDELs
Overall, 8836 of the 10,003 INDELs on our arrays (88.4%) showed
allelic variation in the panel of 158 diverse humans that was ex-
amined (Fig. 3E; Supplemental Table 8). For an additional 212
(2.1%) INDELs, we detected solely the
trace (B) allele. Since the trace allele is
highly abundant and also differs from the
reference genome, these INDELs also
were confirmed. This is a high confirma-
tion rate (90.5%), given that we did not
probe all of the original humans that
were used for INDEL discovery. In many
of the remaining cases (649/955 or 68%),
the trace allele was confirmed in multiple
traces, in the chimp genome, or in the
Celera genome (or combinations of these
three). Likewise, our INDEL detection
pipeline has a validation rate of 97.2%
(Mills et al. 2006), further supporting the
conclusion that most of the remaining
variants are likely to be rare but authentic
INDELs.
Our microarrays allowed us to mea-
sure the allelic frequencies of our INDELs
in the population that was examined (Fig.
3E; Supplemental Table 8). A total of 7728
(77.3%)of the 10,003 INDELs had minor
allelic frequencies that were $5%, and
the remaining 2275 (22.7%) had minor
allelic frequencies of <5%. Thus, the ma-
jority of INDELs detected in our trace
experiments meet the definition of com-
mon human genetic variation (Fig. 3E;
Table 2; Supplemental Table 8). We also
examined the allelic frequencies of INDELs
that mapped to RefSeq genes (Table 2;
Supplemental Tables 8, 10). Although
only 22.7% of the 10,003 INDELs on the
array were rare (MAF <5%), a much larger
percentage of the coding INDELs on the
array were rare (72/111 or 64.9%), sug-
gesting that purifying selection was act-
ing on these alleles. In contrast to the data
in Figure 2A, these population frequency
data indicate that even the coding INDELs
that we can observe are enriched for dele-
terious variants compared to noncoding
INDELs. A two-tailed Fisher’s exact test
revealed that this result was highly signifi-
cant (P = 6.6 3 1021) (Table 2). We also
examined the number of triplet (in-frame)
versus nontriplet (frameshifting) coding
INDELs andobserved an enrichment of rare
alleles among thenontriplet (frameshifting)
group. These data indicate that frameshift-
ing INDELs are under the strongest negative
selection (P = 0.00036), which is not sur-
prising given that this class is expected to be
the most disruptive. These data provide ev-
idence that even the coding INDELs that
have not yet been eliminated by selection
are enriched for deleterious alleles and are likely to have an impact on
humans.
We next examined INDEL inheritance patterns in the 30
Yoruban (YRI) trios that were examined in our study (containing
a mother, father, and child). Ninety-nine percent of the INDELs
Figure 3. Affymetrix INDEL genotyping arrays. (A–C) A region of a custom Affymetrix INDEL
microarray is shown following hybridization and scanning using protocols established for the Affymetrix
6.0 array. Section C contains 1500 Affymetrix SNPs that were developed for the HapMap project and are
also present on the SNP 6.0 array. These were included as positive controls. The average cqc for our
arrays after excluding arrays with scores below 0.4 was 2.2, with a range of 0.53–3.67. The call rate was
96.1%. Section B contains a manufacturing control. Section A represents the remainder of the array,
which contains INDEL probes. (D) Plot of signal intensities for a typical set of INDEL probes following
BRLLM-P analysis. Note that three distinct clusters were obtained for the three INDEL states (AA, AB, BB).
PCR validation studies were conducted in parallel to evaluate the accuracy of the calls (Supplemental
Table 9). A typical result is shown for INDEL 210917. The 24 individuals from the polymorphism dis-
covery resource (PDR) (Collins et al. 1999) that were sampled by PCR are shown in red (the calls were
100% concordant between the arrays and the PCRs). The overall validation rate with 12 representative
INDEL assays in 24 individuals was 99% (Supplemental Table 9). (E ) Allelic frequencies. The allelic fre-
quencies are plotted for the 10,003 INDELs that were examined on the INDEL microarrays (Supple-
mental Table 8). Although the majority of variation meets the definition of common genetic variation
(where the minor allele has a frequency of$5%), rare INDELs also were identified. (F ) Structure plot of
INDEL data. The INDEL genotypes from our arrays were analyzed for population substructure. The PDR
panel, which was designed to capture global diversity, has a large degree of substructure (as indicated
by the colored peaks; right). The Yoruban (YRI) and CHB populations also have some residual sub-
structure. (G) Population-specific INDEL variation. INDELs were identified where both INDEL alleles were
present in one population but only one allele was present in the other. An example of a YRI-specific
INDEL is shown. Note that both A and B alleles are present in the YRI population (and all three genotypes
are present), whereas only the B allele (and one genotype) is present in the CHB population. The INDEL
shown (1384822) is a 3-bp coding INDEL. (H) An example of a CHB-specific INDEL.
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were inherited in a Mendelian fashion in the YRI trios, indicating
that most of the small INDELs in our study are polymorphisms
rather than de novo mutations (Supplemental Table 8). The
remaining 1% of the INDELs had non-Mendelian transmission
patterns. This class of INDELs is likely to be enriched for geno-
typing errors. It should be noted that since the error could be in the
parent or the child, the per sample error rate is <1%. We also de-
termined whether the allelic distributions were in agreement with
Hardy-Weinberg predictions in each of
the three subpopulations that were gen-
otyped (i.e., the polymorphism discovery
resource [PDR], YRI, and Han Chinese
[CHB] populations) (Supplemental Table
11). An average of 96.8% of the INDELs
were in Hardy-Weinberg equilibrium in
the three populations (P = 0.01). Al-
though statistical and genotyping errors
alone can account for the non-HWE dis-
tributions observed, it is also possible that
some of these unusual distributions were
caused by sample relatedness (Fig. 3F) or
natural selection.
We also compared the allelic fre-
quencies of our INDELs in two diverse
human populations (YRI and CHB) (Fig.
3F–H). A total of 2106 (21.1%) of the
INDELs on our arrays had variation in
one of the two populations but not in the
other (Fig. 3G,H; Supplemental Table 12).
Interestingly, most (1748) of these pop-
ulation-specific variants were YRI-specific
variants (in these cases, the YRI pop-
ulation had both INDEL alleles but the
CHB population had only one of the two
alleles) (Fig. 3G). An additional 554 (5.5%)
of the INDELs had allelic frequency dif-
ferences of >0.5 between the two pop-
ulations.
Linkage disequilibrium with SNPs
We next examined the linkage disequi-
librium (LD) of our INDELs compared to
the SNPs that have been genotyped in the
YRI and CHB populations by the HapMap project (The In-
ternational HapMap Consortium 2005). A total of 5218 INDELs
had perfect LD (r2 = 1) with at least one SNP in the CHB HapMap
panel, and 6084 INDELs had useful LD (r2 > 0.8) (Supplemental
Table 13). Likewise, 5674 INDELs had useful LD with SNPs that
were genotyped in the YRI HapMap panel (r2 > 0.8). Most of the
INDELs that had variation on our arrays (8836 or 88.4%) were in
LD with at least one SNP in the CHB and/or YRI populations (Fig.
4A). These experiments demonstrate that thousands of small
INDELs can be efficiently genotyped and integrated into the hu-
man HapMap with this approach.
Finally, we determined whether high-scoring SNPs from ge-
nome-wide association studies likewise had high levels of LD with
any of our INDELs. Such associations could establish connections
between our INDELs and human traits (including diseases). More
than 56,000 SNPs from 118 published genome-wide association
studies recently were collected into a single convenient database
(Supplemental Table 14; Johnson and O’Donnell 2009). We used
this database to determinewhether any of the SNPs in these studies
had high levels of pairwise LD with our INDELs. Indeed, this ap-
proach was highly successful, and 2290 SNPs were identified that
had high levels of LD (r2 > 0.8) with our INDELs (Supplemental
Table 15). In fact, 1193 SNPs had perfect LD (r2 = 1) with INDELs on
our arrays (Fig. 4B). Almost half of the INDELs (1102 or 48%) were
located in genes (Fig. 4B), and many of these INDELs could be
envisioned to affect gene function (Fig. 4C). Thus, in conjunction
Table 2. Analysis of rare INDEL variants in RefSeq genes
Class Number of rare/total % P-value
All INDELs on array 2,275/10,003 22.7 N/A
In RefSeq genes 1,050/4,466 23.5 0.32
Not in RefSeq genes 1,225/5,537 22.1 0.38
Exon (coding) 72/111 64.9 6.6 3 1021
Exon (noncoding) 32/122 26.2 0.39
Intron 895/4,044 22.1 0.44
Promoter 36/132 27.3 0.21
Terminator 15/57 26.3 0.53
For each class of INDELs examined, the number of rare INDELs (MAF <5%)
versus the total number of INDELs in the class is listed. Two-tailed Fisher’s
exact tests were performed between the overall set of 10,003 INDELs that
were genotyped on the array and each of the other classes that are listed.
The data indicate that rare INDELs are over-represented in coding exons
compared to the 10,003 INDELs. None of the remaining classes had such
enrichment, suggesting that coding exons are themost sensitive to INDELs.
Figure 4. Linkage disequilibrium between SNPs and INDELs. (A) The r2 value was calculated for each
SNP within a 1-Mb window of a given INDEL using the SNP genotypes that have been reported for
HapMap 3 (http://hapmap.ncbi.nlm.nih.gov/) and our INDEL genotyping data from the same samples.
For each population (YRI, CHB), the SNPwith themaximum r2 value was identified (Supplemental Table
13). INDELs in perfect LD with a SNP have an r2 of 1.0. (B) LD also was examined for high-scoring SNPs
(with P-values <0.001) that were identified in 118 GWAS studies (Supplemental Table 14; Johnson and
O’Donnell 2009). GWAS SNPs that have high levels of LD (r2 > 0.8) with INDELs are summarized. (C )
Examples of INDELs from B that map to functional regions of genes. The 16 examples were taken from
a larger collection of 1102 INDELs that have high levels of LD with GWAS SNPs and also map to genes
(Supplemental Table 15).
Small INDELs in human genomes
Genome Research 835
www.genome.org
 Cold Spring Harbor Laboratory Press on October 22, 2020 - Published by genome.cshlp.orgDownloaded from 
withGWAS studies, our INDEL genotyping platform can be used to
identify INDEL candidates that may influence human traits and
diseases.
Discussion
We provide strong evidence that small INDEL variation is not only
abundant in humans but is also likely to contribute to human
phenotypic diversity. More than 800,000 of the small INDELs in
our study mapped to human genes, including 2123 small INDELs
that mapped to the coding exons of these genes (Fig. 2; Supple-
mental Tables Chr1–ChrY; Supplemental Table 5). Many of these
coding INDELs would be expected to alter gene function (Fig. 2;
Table 2; Supplemental Tables 5, 6; Taylor et al. 2004). We also
identified more than 39,000 INDELs in the promoter regions of
genes (Supplemental Tables Chr1–ChrY). Such INDELs could be
envisioned to contribute to the allele-specific gene expression
differences that have been observed in humans (Yan et al. 2002;
Cheung et al. 2003; Cheung and Spielman 2009). Taken together,
these two classes of INDELs alone (coding and promoter INDELs)
are likely to harbor many variants that affect human biology.
Several independent lines of evidence indicate that coding
INDELs in particular are likely to be detrimental in humans. First,
we found that ;75% of the INDELs that arise in coding exons
appear to be eliminated by strong purifying selection (Fig. 2A).
Moreover, our INDEL genotyping experiments further indicated
that most of the remaining coding INDELs are also under selective
pressure as revealed by an over-representation of rare alleles in this
class (Table 2). Taken together, these data indicate that coding
INDELs in general, and frameshifting INDELs in particular, have
negative effects on human gene function. A comparison of our
most detrimental coding INDELs with targeted deletions of
orthologousmouse genes provided additional support for this idea
(Supplemental Tables 5, 6). Finally, many of our INDELs (including
coding INDELs) were in perfect LD with high-scoring SNPs that
have been identified previously in GWAS studies (Fig. 4). There-
fore, it is likely that coding INDELs and any associated effects are
being detected in these studies. Taken together, these observations
suggest that coding INDELs (particularly those that cause frame-
shifts) are likely to be responsible for a great deal of phenotypic
diversity and diseases in humans.
Coding INDELs also have been identified in at least some of
the personal human genomes that have been sequenced. For ex-
ample, several hundred coding INDELs have been identified in the
Venter (Ng et al. 2008) andWatson (Wheeler et al. 2008) genomes.
Although coding INDELs have not been reported in most of the
other personal genomes that have been sequenced, it is not clear
whether attempts were made to identify coding INDELs in these
studies. Our data suggest that coding INDELs are likely to be present
in all human genomes (Fig. 2; Supplemental Tables 5, 10). In further
support of this conclusion, exome re-sequencing projects and the
1000Genomes Project also have identified coding INDELs (Ng et al.
2009, 2010; The 1000 Genomes Project Consortium 2010).
INDEL microarrays for genotyping
Salathia et al. (2007) previously described an approach for geno-
typing INDELs in the size range of 25 bp to 7260 bp in Arabidopsis
thaliana. These INDELs were genotyped using 70-mer oligonucle-
otide probes and Comparative Genome Hybridization (CGH). In
contrast, our approach more closely resembles the methods that
were developed for SNP genotyping on the Affymetrix 6.0 array
(The International HapMap Consortium 2005). In particular, we
derived statistical clustering models from population data to call
the INDEL genotypes using BRLMM-P. However, in contrast to the
Affymetrix 6.0 approach, we used a series of 25-mer probes that
spanned the unique junctions of INDEL alleles (Supplemental Fig.
5). Thus, our approach is unique compared to both the CGH and
the SNP-based approaches that are outlined above. The smaller
(25-mer) oligonucleotide probes that were employed with our
Affymetrix platform can discriminate alternative INDEL alleles
that differ by as few as 1 to 25 bp, and these probes performed well
over the entire range that was tested in our study (1 bp to 100 bp).
This size range is ideal for human INDELs because >99% of human
INDELs are smaller than 100 bp and most human INDELs are
smaller than 25 bp (Supplemental Fig. 2). Although our initial ar-
ray contained a relatively small number of INDEL assays (10,003),
this approach is directly scalable to much larger Affymetrix array
formats.
In the past, genotyping arrays have been extremely valuable
for validating and genotyping the SNPs that have been discovered
by DNA sequencing (The International HapMap Consortium
2005). Since INDEL array technologies have lagged behind SNP
arrays, it has not been possible to perform similar follow-up studies
on the small INDELs that have been discovered in personal human
genomes and populations. Our approach now can be used to
perform these studies. The several million INDELs that have been
discovered in personal human genomes and populations now can
be validated with our platform. This approach will be particularly
useful for genotyping INDELs that have eluded detection with
Illumina-based sequencing due to the complexities of mapping
short reads that involve INDELs. Thus, even as the price of whole-
genome sequencing continues to drop, array-based technologies
are likely to play a complementary role in validating and geno-
typing INDELs.
Our study argues that small INDELs should be fully discov-
ered, genotyped, and integrated into the human HapMap. INDELs
that map to coding exons, promoters, and other functionally im-
portant sites could be given the highest priority. Our custom
INDEL array technology now provides a means for accomplishing
this goal. Larger array formats could be designed and manufac-
tured to genotype the several million INDELs that have been dis-
covered by us and others. Once integrated into the HapMap, these
small INDELs could be readily detected through imputation, thus
facilitating efforts to identify high-scoring markers and causative
variants in GWAS studies. As efforts turn to routine whole-genome
re-sequencing, small INDELs could be imputed from the SNPs that
are detected using this integrated map of phased variation. Small
INDELs can be technically challenging to detect with next-gener-
ation trace mapping, and this would provide an alternative way to
detect and annotate small INDELs. The largest and most in-
teresting challenge ahead will be to use medical histories, treat-
ment successes, and other phenotypes to identify specific INDELs
that affect human biology, with the overall goal of developing
a comprehensive framework of predictive health.
Methods
INDEL discovery pipeline
Our INDEL discovery pipeline has been described previously (Mills
et al. 2006). In this earlier study, we conducted a series of PCR-
based validation studies with variants that were detected by our
pipeline (Mills et al. 2006). In particular, we examined 215 variants
Mills et al.
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using PCR-based methodologies and validated 209/215 (97.2%) of
the variants. Importantly, these validation studies were carried out
with the same 24 humans that were used for INDEL discovery (24
humans from the polymorphism discovery resource) (Collins et al.
1999). Thus, we knew with certainty that any variant identified
in these traces also should be found by PCR in the 24 humans. We
examined a range of INDEL sizes and sequences in this validation
study, including single-base-pair INDELs, repeat expansions,
transposon insertions, coding INDELs, and SNPs. We achieved an
overall validation rate of 97.2% (false discovery = 2.8%).
In our previous study, we found that a single ABI Sanger trace
was sufficient to accurately identify INDELs >1 bp in length (from2
bp to 10,000 bp) (Mills et al. 2006). However, single-base-pair
INDELs were less accurately called by a single trace, and we
implemented a double hit rule to call 1-bp INDELs. This led to
a similarly high validation rate (97.3%) for single-base-pair INDELs
(Mills et al. 2006). The number of times that a given INDEL was
detected in traces is indicated in Supplemental Tables Chr1–ChrY.
We also used the chimp and Celera genomes to evaluate whether
the trace alleles could be validated by at least one additional source
(Table 1; Supplemental Tables Chr1–ChrY; Mills et al. 2006).
Identification and analysis of INDELs from NCBI trace data
DNA traces were obtained from the trace archive at NCBI (http://
www.ncbi.nlm.nih.gov/Traces/trace.cgi). Traces were processed
and compared to the hg18 build of the human genome using
quality scores to guide the analysis, as described previously (Mills
et al. 2006). INDELs were defined as insertions or deletions in the
1-bp to 10,000-bp size range that could be detected by comparing
ABI traces to the reference genome as outlined previously (Tsui
et al. 2003; Bennett et al. 2004; Mills et al. 2006). All variants were
entered into a Perl dbfile hash module to identify redundancies,
and then into a MySQL database, which was used to store and
analyze the data. Supplemental Tables Chr1 to ChrY contain all
of our variants along with coordinates and other information.
INDELs weremapped to RefSeq genes as follows. First, RefSeq gene
tracks were obtained from the UCSC Human Genome Browser
(http://www.genome.ucsc.edu). The coordinates of our variants
were compared to the coordinates of all RefSeq genes to identify
variants that overlapped these genes (and specific features within
these genes). For coding INDELs, this processwas repeatedwith the
Ensembl gene track downloaded from the Ensembl site (http://
www.ensembl.org), and a non-overlapping set was developed.
Additional annotation was obtained from the RefSeq database at
NCBI (http://www.ncbi.nlm.nih.gov/RefSeq) and OMIM (http://
www.ncbi.nlm.nih.gov/Omim).
Affymetrix INDEL microarrays
Custom Perl scripts were written to identify INDELs that would be
suitable for probing on Affymetrix arrays using protocols that have
been developed for SNPs (http://www.affymetrix.com). For ex-
ample, to adapt our INDELs to the reduced representation probing
that is used for SNPs, we identified INDELs that fell within three
size intervals of StyI/NspI restriction fragments: (1) 0.2–0.8 kb, (2)
0.8–1 kb, (3) 1 0–1.2 kb. Group 1 was the preferred size, but the
other size ranges also were included, if necessary. Probes were de-
veloped as outlined in Supplemental Figure 5. Probes were com-
pared to the RepeatMasker track of the human genome (build
hg18) andwere set aside if they overlapped known repeats. In some
cases, probes were designed for INDELs involving repeat expan-
sions and transposons, and these probes were allowed to contain
repeats. Such probes generally did not perform well and were fil-
tered out at later stages (see below). Probes also were compared to
the SNPs and INDELs present in build 128 of dbSNP, and probes
that overlapped SNPs or other INDELs were not used. One thou-
sand five hundred SNP probe sets from the Affymetrix 6.0 SNP
array were included on our arrays as positive controls and for
quality-control analysis. Arrays were hybridized using the Affy-
metrix 6.0 array kits and protocols (http://www.affymetrix.com).
The Affymetrix Power Tools (APT) software package (http://www.
affymetrix.com/support/developer/powertools/changelog/index.
html) was modified to handle INDEL cdf files and the multiple
probe designs that are required for INDELs. CEL files were nor-
malized, and the quality was assessed using the APT program
apt-geno-qc. High-quality arrays (cqc >0.4) were analyzed with the
APT program apt-probeset-genotype using BRLLM-P at a cutoff
of 0.05.
The select probes feature in the Affymetrix APT software was
used to identify the best probes from all of the initial probes that
were included on the array. For each INDEL, between 12 and 24
probes (depending on the INDEL type) were included on the array
to discriminate between the two INDEL states (Supplemental Fig.
5). The best-performing probes were identified using a combined
cutoff of AIC value <325, and FLDAB >3. Both the AIC and FLDAB
parameters are derived from the clustering data and provide mea-
sures of an assay’s ability to discriminate the A and B states. The
probes that were selected at these cutoffs were able to discriminate
the two INDEL alleles very well and had excellent clustering
properties in BRLLM-P as well as high validation rates. All other
probes were filtered from further consideration. Assays that had
more than 60 no calls also were removed. This approach led to
a final set of 10,003 assays that were used for all remaining studies.
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